CRIS Current Research Information System

ZUFFA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.997
AS - Asia 1.808
EU - Europa 1.454
AF - Africa 106
SA - Sud America 85
Continente sconosciuto - Info sul continente non disponibili 83
OC - Oceania 2
Totale 5.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.951
VN - Vietnam 562
SG - Singapore 496
CN - Cina 404
GB - Regno Unito 363
SE - Svezia 213
DE - Germania 197
IT - Italia 178
FR - Francia 98
HK - Hong Kong 90
UA - Ucraina 84
IN - India 71
RU - Federazione Russa 67
NL - Olanda 65
BR - Brasile 51
IE - Irlanda 51
JP - Giappone 45
TG - Togo 30
ZA - Sudafrica 30
CA - Canada 29
FI - Finlandia 29
EE - Estonia 27
NG - Nigeria 22
BD - Bangladesh 21
KR - Corea 19
PH - Filippine 17
BG - Bulgaria 15
JO - Giordania 15
BE - Belgio 12
AR - Argentina 11
CI - Costa d'Avorio 10
IQ - Iraq 9
PK - Pakistan 9
PL - Polonia 9
TH - Thailandia 9
EC - Ecuador 8
CH - Svizzera 7
MX - Messico 7
AT - Austria 6
ES - Italia 6
HR - Croazia 6
SC - Seychelles 6
TR - Turchia 6
PY - Paraguay 5
GR - Grecia 4
ID - Indonesia 4
IR - Iran 4
MY - Malesia 4
RO - Romania 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
EU - Europa 3
GT - Guatemala 3
JM - Giamaica 3
LT - Lituania 3
NP - Nepal 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
DK - Danimarca 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.456
Salva come PNG Salva come JPEG
Città #
Singapore 355
Southend 322
Ashburn 231
Dong Ket 201
Chandler 179
San Jose 123
Fairfield 117
Ho Chi Minh City 94
Ann Arbor 92
Hong Kong 84
Hanoi 83
Beijing 78
Seattle 74
Wilmington 73
Houston 68
Woodbridge 66
Princeton 58
Dublin 51
Santa Clara 49
Jacksonville 47
Boardman 46
Tokyo 43
Cambridge 42
New York 40
Council Bluffs 39
Lomé 30
Los Angeles 30
Padova 30
Hefei 29
Lauterbourg 29
Westminster 29
Nanjing 27
Bologna 25
Helsinki 22
Medford 22
Munich 20
Berlin 19
Jinan 19
Abeokuta 17
Frankfurt am Main 17
Milan 17
Amman 15
Sofia 15
Changsha 13
Haiphong 13
Saint Petersburg 13
Brussels 12
Toronto 12
Seoul 11
Abidjan 10
Bremen 10
Da Nang 10
Redondo Beach 10
Hebei 9
Shanghai 9
Falkenstein 8
Guangzhou 8
Phoenix 8
São Paulo 8
Buffalo 7
Hải Dương 7
Jiaxing 7
Orem 7
Paris 7
Redwood City 7
San Diego 7
Shenyang 7
Dallas 6
Falls Church 6
Nanchang 6
Romainville 6
San Francisco 6
Turin 6
Turku 6
Atlanta 5
Baghdad 5
Brooklyn 5
Bühl 5
Chicago 5
Hangzhou 5
Mountain View 5
Mülheim 5
Quito 5
Rome 5
Shijiazhuang 5
Xi'an 5
Zhengzhou 5
Bangkok 4
Bern 4
Bến Tre 4
Chengdu 4
Dearborn 4
Düsseldorf 4
Florence 4
Johannesburg 4
Kingston 4
Kunming 4
Kyiv 4
Long Xuyen 4
Montreal 4
Totale 3.446
Salva come PNG Salva come JPEG
Nome #
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 294
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 281
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 257
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 240
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 236
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 219
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 215
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 215
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 194
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 193
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 193
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 189
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 189
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 186
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 182
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 181
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 178
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 177
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 176
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 166
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 164
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. 162
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 162
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 159
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 154
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 154
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 152
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 135
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 132
Totale 5.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022546 0 0 36 66 55 32 16 26 27 41 124 123
2022/2023710 98 97 47 90 50 58 15 35 116 22 50 32
2023/2024193 4 31 5 34 14 53 14 9 7 8 7 7
2024/2025648 11 102 57 51 75 23 67 27 6 84 18 127
2025/20261.634 141 92 111 91 248 93 129 42 431 143 48 65
2026/2027173 33 57 83 0 0 0 0 0 0 0 0 0
Totale 5.535